In laboratory research, the Drug Affinity Complex is studied for its binding to serum albumin and its effect on half-life. Preclinical models examine CJC-1295 DAC in relation to GH- and IGF-1-related signaling over extended time courses.
In laboratory research, the Drug Affinity Complex is studied for its binding to serum albumin and its effect on half-life. Preclinical models examine CJC-1295 DAC in relation to GH- and IGF-1-related signaling over extended time courses.